Hepatitis B vaccination in dialysis centres: advantages and limits.
A review is presented on the results achieved in HBV immunization of hemodialysis patients with aluminum-adsorbed, subunit plasma-derived and yeast-derived vaccines. The main host-related and immunization-related causes of low response are discussed. Various possibility to improve the vaccine performance through appropriate dosage and schedule, as well as immunopotentiating procedures are reported.
Rapicetta
M
M
Department of Virology, Istituto Superiore di Sanità, Rome, Italy.
D003428:Cross Infection / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines; D006801:Humans; D006435:Renal Dialysis / Q000009:adverse effects*; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines